Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Forte Biosciences
FBRX
$1.57B
| $1.63M | ﹤0.01% |
108,318
+44,208
| +69% | +$509K |
|
3252
Strive Inc
ASST
$1.07B
| $1.62M | ﹤0.01% |
32,489
+25,010
| +334% | +$2.38M |
|
3253
Structure Therapeutics
GPCR
$3.89B
| $1.62M | ﹤0.01% |
57,958
+3,777
| +7% | +$75.2K |
|
3254
Corbus Pharmaceuticals
CRBP
$195M
| $1.62M | ﹤0.01% |
127,731
-6,360
| -5% | -$60.5K |
|
3255
C4 Therapeutics
CCCC
$502M
| $1.61M | ﹤0.01% |
725,304
-19,749
| -3% | -$47.4K |
|
|
LB
3256
LandBridge Co
LB
$2.1B
| $1.61M | ﹤0.01% |
30,168
+1,197
| +4% | +$66K |
|
|
ORBS
3257
Eightco Holdings
ORBS
$291M
| $1.61M | ﹤0.01% |
175,726
+156,784
| +828% | +$857K |
|
3258
Achieve Life Sciences
ACHV
$743M
| $1.6M | ﹤0.01% |
506,977
+144,777
| +40% | +$397K |
|
3259
Pulmonx
LUNG
$92.8M
| $1.59M | ﹤0.01% |
978,762
+49,365
| +5% | +$103K |
|
3260
Mercer International
MERC
$33.6M
| $1.57M | ﹤0.01% |
546,398
+7,334
| +1% | +$24.2K |
|
3261
Patriot National Bancorp
PNBK
$131M
| $1.57M | ﹤0.01% |
1,208,828
+162,612
| +16% | +$245K |
|
|
ATYR
3262
aTyr Pharma
ATYR
$54.7M
| $1.57M | ﹤0.01% |
2,178,203
+80,127
| +4% | +$363K |
|
3263
Fuel Tech
FTEK
$45.6M
| $1.57M | ﹤0.01% |
523,818
+6,160
| +1% | +$17.9K |
|
|
SUPX
3264
SuperX AI Technology Ltd
SUPX
$300M
| $1.57M | ﹤0.01% |
24,294
+9,295
| +62% | +$310K |
|
|
FLNA
3265
Filana Therapeutics
FLNA
$45.9M
| $1.57M | ﹤0.01% |
537,901
+15,022
| +3% | +$34.5K |
|
3266
Comstock
LODE
$263M
| $1.56M | ﹤0.01% |
456,246
+179,147
| +65% | +$558K |
|
3267
Travelzoo
TZOO
$74.7M
| $1.55M | ﹤0.01% |
157,994
+727
| +0.5% | +$7.82K |
|
|
HURA
3268
TuHURA Biosciences
HURA
$146M
| $1.54M | ﹤0.01% |
622,771
+39,779
| +7% | +$105K |
|
3269
Cardlytics
CDLX
$25.4M
| $1.54M | ﹤0.01% |
63,356
+100
| +0.2% | +$1.67K |
|
|
MGRM
3270
DELISTED
Monogram Orthopaedics
MGRM
| $1.54M | ﹤0.01% |
261,722
+18,344
| +8% | +$98K |
|
3271
Fresenius Medical Care
FMS
$12.6B
| $1.52M | ﹤0.01% |
57,905
| – | – |
|
3272
Altisource Portfolio Solutions
ASPS
$65.1M
| $1.52M | ﹤0.01% |
130,566
+15,297
| +13% | +$175K |
|
3273
Denison Mines
DNN
$2.94B
| $1.52M | ﹤0.01% |
550,016
+59,536
| +12% | +$132K |
|
3274
Vivid Seats
SEAT
$81.2M
| $1.52M | ﹤0.01% |
91,276
-4,070
| -4% | -$96K |
|
|
GPMT
3275
Granite Point Mortgage Trust
GPMT
$59.3M
| $1.52M | ﹤0.01% |
505,245
-15,731
| -3% | -$43.4K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.